Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mar Tintore

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 10, 2016
CSF examination still has value in the diagnosis of MS - CommentaryGeorgina Arrambide, Mar Tintore
Expert Review of Neurotherapeutics|November 9, 2019
Diagnosis of multiple sclerosis: what is changing?Georgina Arrambide, Mar Tintore
Neurology|October 14, 2016
Sustained reduction of MS disability: New player in comparing disease-modifying treatmentsBibiana Bielekova, Mar Tintore
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2019
An asymptomatic new lesion on MRI is a relapse and should be treated accordingly - CommentaryGeorgina Arrambide, Mar Tintore
Neurology|March 15, 2013
MRI criteria distinguishing seropositive NMO spectrum disorder from MSMar Tintore, Alex Rovira
Neurology|June 12, 2026
Redefining Multiple Sclerosis: Toward a Biologically Driven DiagnosisMar Tintore, Àlex Rovira
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 3, 2014
Understanding the role of gender and hormones in multiple sclerosisMar Tintore, Carmen Tur
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 11, 2022
Multiple sclerosis in the Middle East and North Africa regionSamia J Khoury, Mar Tintore
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2024
Prioritizing global strategies to cure MSAlvaro Cobo-Calvo, Mar Tintore
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 16, 2021
DMTs should be trialed in individuals with PPMS and SPMS with or without recent disease activity - CommentaryRobert J Fox, Mar Tintore
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 10, 2016
CSF examination still has value in the diagnosis of MS - CommentaryGeorgina Arrambide, Mar Tintore
Expert Review of Neurotherapeutics|November 9, 2019
Diagnosis of multiple sclerosis: what is changing?Georgina Arrambide, Mar Tintore
Neurology|October 14, 2016
Sustained reduction of MS disability: New player in comparing disease-modifying treatmentsBibiana Bielekova, Mar Tintore
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2019
An asymptomatic new lesion on MRI is a relapse and should be treated accordingly - CommentaryGeorgina Arrambide, Mar Tintore
Neurology|March 15, 2013
MRI criteria distinguishing seropositive NMO spectrum disorder from MSMar Tintore, Alex Rovira
Neurology|June 12, 2026
Redefining Multiple Sclerosis: Toward a Biologically Driven DiagnosisMar Tintore, Àlex Rovira
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 3, 2014
Understanding the role of gender and hormones in multiple sclerosisMar Tintore, Carmen Tur
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 11, 2022
Multiple sclerosis in the Middle East and North Africa regionSamia J Khoury, Mar Tintore
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2024
Prioritizing global strategies to cure MSAlvaro Cobo-Calvo, Mar Tintore
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 16, 2021
DMTs should be trialed in individuals with PPMS and SPMS with or without recent disease activity - CommentaryRobert J Fox, Mar Tintore
Pageof 7